Back to Search
MICHAEL COVINGTON, DO
DO
Family Medicine Physician
NPI: 1295359743IndividualAccepts Medicare
Specialties, Licenses & Credentials
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
OP61278492(WA)
CMS Specialties
PrimaryFAMILY PRACTICE
Education
PACIFIC NW UN OF HS, COL OF OSTEOPATHIC MEDICINE
Class of 2020
Research & Publications (20)
Time-resolved measurement of propagating spin waves in ferromagnetic thin films.
PMID 12485035·Phys Rev Lett·2002
8-other
Discovery of novel selective HER-2 sheddase inhibitors through optimization of P1 moiety.
PMID 19635666·Bioorg Med Chem Lett·2009
8-other
Calpain 10 is required for cell viability and is decreased in the aging kidney.
PMID 19144693·Am J Physiol Renal Physiol·2009
7-preclinical
Ketamine and schizophrenic speech: more difference than originally reported.
PMID 18562422·J Psychopharmacol·2009
8-other
Compelling P1 substituent affect on metalloprotease binding profile enables the design of a novel cyclohexyl core scaffold with excellent MMP selectivity and HER-2 sheddase inhibition.
PMID 19457660·Bioorg Med Chem Lett·2009
8-other
Pharmacological characterization of INCB3344, a small molecule antagonist of human CCR2.
PMID 19576173·Biochem Biophys Res Commun·2009
8-other
Two-week treatment with the selective serotonin reuptake inhibitor citalopram reduces contextual anxiety but not cued fear in healthy volunteers: a fear-potentiated startle study.
PMID 18800069·Neuropsychopharmacology·2009
2-rct
Alpha,Beta-cyclic-beta-benzamido hydroxamic acids: Novel oxaspiro[4.4]nonane templates for the discovery of potent, selective, orally bioavailable inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).
PMID 18234496·Bioorg Med Chem Lett·2008
7-preclinical
Mitochondrial calpain 10 activity and expression in the kidney of multiple species.
PMID 18054326·Biochem Biophys Res Commun·2008
7-preclinical
Alpha,beta-cyclic-beta-benzamido hydroxamic acids: novel templates for the design, synthesis, and evaluation of selective inhibitors of TNF-alpha converting enzyme (TACE).
PMID 18061445·Bioorg Med Chem Lett·2008
7-preclinical
Conversion of an MMP-potent scaffold to an MMP-selective HER-2 sheddase inhibitor via scaffold hybridization and subtle P1' permutations.
PMID 18068976·Bioorg Med Chem Lett·2008
8-other
Modality-specific attention under imminent but not remote threat of shock: evidence from differential prepulse inhibition of startle.
PMID 18578853·Psychol Sci·2008
8-other
Global transcriptome analysis reveals circadian regulation of key pathways in plant growth and development.
PMID 18710561·Genome Biol·2008
4-observational
Design and identification of selective HER-2 sheddase inhibitors via P1' manipulation and unconventional P2' perturbations to induce a molecular metamorphosis.
PMID 18036818·Bioorg Med Chem Lett·2008
8-other
Potent, exceptionally selective, orally bioavailable inhibitors of TNF-alpha Converting Enzyme (TACE): novel 2-substituted-1H-benzo[d]imidazol-1-yl)methyl)benzamide P1' substituents.
PMID 18242982·Bioorg Med Chem Lett·2008
7-preclinical
Potent, selective, orally bioavailable inhibitors of tumor necrosis factor-alpha converting enzyme (TACE): discovery of indole, benzofuran, imidazopyridine and pyrazolopyridine P1' substituents.
PMID 18282708·Bioorg Med Chem Lett·2008
7-preclinical
Decreased iPLA2gamma expression induces lipid peroxidation and cell death and sensitizes cells to oxidant-induced apoptosis.
PMID 18398221·J Lipid Res·2008
7-preclinical
Discovery of beta-benzamido hydroxamic acids as potent, selective, and orally bioavailable TACE inhibitors.
PMID 18032037·Bioorg Med Chem Lett·2008
7-preclinical
Automatic measurement of propositional idea density from part-of-speech tagging.
PMID 18522065·Behav Res Methods·2008
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3907 CREEKSIDE LOOP STE 100
YAKIMA, WA 98902 - Phone
- (509) 895-7535
Quick Facts
- NPI
- 1295359743
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 6
- Publications
- 20
Are you this provider?
Claim Your Profile